Dr. Reddy's Laboratories United States

Note: I will be out of the office Oct 5-16. I will have partial access to email Oct 5-9. If I don't reply during that time, I will reply upon my return on Oct 19.

Sam Lee
Director 

A C BINDER CORP United States

We are  a group of investors. We were in manufacturing. were autsorsed, now in investing.  We are family members

Mr Henry Maslowski
VP 

Accenture United States

Mr Nicolae Cecan
Digital Strategy Consultant 

Accenture United States

Gaurav J. Shah, PhD, MBA
Accenture Strategy 

Accessium Group Inc. United States

Seamless access to critical data. Customer support that never stops. 21st-century ingenuity combined with good old-fashioned integrity. That's Accessium. No matter what business you're in, our custom solutions will take your data efficiency and security to the next level.

Specialties

PACS/Radiology/Cardiac/Ortho Systems, HealthCare Information Technology, Moblie Application Integration, Network Security/Auditing, Server and Network Architecture/Design/Support

Mr John Hatcher
VP of Business 
Mr Ryan Erwin
CEO 

Adjuvance Technnologies United States

Adjuvance Technologies, Inc. is a privately owned biopharmaceutical company dedicated to empowering global health through fundamental breakthroughs in vaccine adjuvant design and manufacturing.

Adjuvance’s founders, including Jeffrey GardnerDavid GinPhilip Livingston and Govindaswami Ragupathi comprise a highly motivated group of experienced individuals eager to commercialize our core technologies in close collaboration with key partnering organizations, such as Memorial Sloan-Kettering Cancer Center.

Our team’s credentials span Medicine, Science and Business. Our world-class experience represents in-depth expertise in chemistry, immunology, adjuvant immunopotentiation and therapeutic vaccinology. Most importantly, our team represents world-leading experience in therapeutic vaccines and vaccine adjuvants, and is experienced in the commercialization of immunotherapeutics.

We believe that our world-class team provides you with more than just a business plan, but a group of impassioned founders and seasoned professionals that are capable of seeing through our mission.

Mr Jeffrey Gardner
President & CBO 

Aetna Innovation Labs United States

Founded in 1853 in Hartford, CT, Aetna is committed to providing individuals, employers, health care professionals, producers and others with innovative benefits, products and services. Discover more about our organization.

Dr Jay Rajda
Medical Director 

AIG United States

Specialties

Property Casualty Insurance, Life and Retirement, Mortgage Guaranty

American International Group, Inc. – also known as AIG – is an American multinational insurance corporation with more than 88 million customers in 130 countries. AIG companies employ over 64,000 people in 90 countries. The company operates through three businesses: AIG Property Casualty, AIG Life and Retirement and United Guaranty Corporation (UGC). AIG Property Casualty provides insurance products for commercial, institutional and individual customers. AIG Life and Retirement provides life insurance and retirement services in the United States. UGC focuses on mortgage guaranty insurance and mortgage insurance. AIG also focuses on global capital markets operations, direct investment and retained interests.

AIG’s corporate headquarters are in New York City

Ms Joyce Segall
Vice President, Global Health Product Development and Design 

Akrivis Technologies, LLC United States

Akrivis (www.akrivis.com) is a privately held biopharmaceutical company based in Cambridge, Massachusetts (USA) and committed to the early detection, diagnosis and treatment of serious and life-threatening diseases. Its patented Z-TECT™ technology platform is in essence a versatile, high payload, sequentially targeted carrier system that provides: (1) ultrasensitive in vitro detection; (2) high resolution in vivo imaging; and (3) efficient and specific, sequentially targeted delivery of high drug payloads to targeted biomarkers with improved efficacy and safety. Beyond targeted therapies and theranostics for oncology, Akrivis has a core focus on children’s health with on-going projects in pediatric oncology (neuroblastoma and ALL with reduced off-target toxicity) as well as Duchenne Muscular Dystrophy (DMD).

Dr Joel BERNIAC
President, CEO and Co-Founder 

Alan Hill United States

Dr Bryan Hill
Dr Bryan Hill